Fingerprint
Dive into the research topics of 'Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer
Kristiaan Lenos, Anna M. Grawenda, Kirsten Lodder, Marieke L. Kuijjer, Amina F.A.S. Teunisse, Emmanouela Repapi, Lukasz F. Grochola, Frank Bartel, Pancras C.W. Hogendoorn, Peter Wuerl, Helge Taubert, Anne Marie Cleton-Jansen, Gareth L. Bond*, Aart G. Jochemsen
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
47
Citations
(Scopus)